About Alphalyse
Alphalyse is a Healthcare company based in Odense (Denmark) founded in 2002, and was acquired by Fidelio Capital in July 2025. Protein analysis services are provided for drug development acceleration. Alphalyse offers products and services including Host Cell Protein Analysis and Product Characterization. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Proteomics. Its legal entity is ALPHALYSE A/S.
Company details
Alphalyse was established in 2002 in Odense, Denmark, within the biotechnology sector. Protein analysis services are offered to aid drug development processes. Impurity analysis and protein characterization are performed via mass spectrometry techniques. Additional services include biopharmaceutical characterization, peptide mapping through mass spectrometry, host cell protein evaluation, and protein quantification in complex biological samples. Operations focus on analytical support for pharmaceutical research and manufacturing.
- Headquarters Odense, Denmark
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website alphalyse.com
- Social LinkedIn X Facebook YouTube
- Acquired by Fidelio Capital (Jul 2025)
- Legal Name Alphalyse A/S
- Latest Funding Round$342.47K (USD), Grant
Oct 2017
- InvestorsEuropean Union
& 1 more
- Acquired byFidelio Capital
(Jul 2025)
Products & Services of Alphalyse
Alphalyse offers a comprehensive portfolio of products and services, including Host Cell Protein Analysis and Product Characterization.
Identifies and quantifies impurities in biologic drugs for safety.
Characterizes proteins and impurities in vaccines and therapies.
Apps and channels of Alphalyse
its YouTube channel Alphalyse A/S has 148 subscribers and 30 videos.
Videos from Alphalyse
The most watched videos on Alphalyse's YouTube channel, Alphalyse A/S (148 subscribers). Click a video to play it here.
More on Alphalyse A/S.
Funding Insights of Alphalyse
- Total Rounds 4
- Last Round Grant β $342,470
- Investors Count 1
All 4 funding rounds of Alphalyse with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2017 | $342,470 | Grant | β | β | |
| Jan 2017 | $306,105 | Grant | β | β | |
| Nov 2016 | $290,000 | Grant | β | β | β |
| Jun 2014 | Grant | β | β | β |
2 investors in total: 2 institutional.
Investors in Alphalyse
Alphalyse has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Fidelio Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fidelio Capital is engaged in global investment to transform businesses. | fideliocapital.com | Stockholm, Sweden | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Alphalyse
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Alphalyse
4 dated milestones of Alphalyse across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Alphalyse is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $342K.
- Exit Acquired by Fidelio Capital.
Web traffic of Alphalyse
The website of Alphalyse (alphalyse.com) receives about 2.9K visits a month.
- Monthly visits2.9K
Websites whose visitors overlap most with Alphalyse. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
proteomefactory.com | proteomefactory.com | 100% | β | ||
| aldevron.com | 86% | 12.5K | #1,963,419 | View details | |
proteindesign.com | proteindesign.com | 83% | β | ||
| eprogen.com | 83% | View details | |||
proteinatlas.org | proteinatlas.org | 82% | #96,467 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 7 similar websites and full traffic analytics for Alphalyse
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Alphalyse
Complete news archive for Alphalyse
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alphalyse
Alphalyse was founded in 2002 and raised its 1st funding round 12 years after it was founded.
Alphalyse is headquartered in Odense, Denmark.
Alphalyse was established in 2002 in Odense, Denmark, within the biotechnology sector. Protein analysis services are offered to aid drug development processes. Impurity analysis and protein characterization are performed via mass spectrometry techniques. Additional services include biopharmaceutical characterization, peptide mapping through mass spectrometry, host cell protein evaluation, and protein quantification in complex biological samples. Operations focus on analytical support for pharmaceutical research and manufacturing.
Alphalyse offers Host Cell Protein Analysis and Product Characterization.
Alphalyse has 2 investors. Key investors include European Union, and Fidelio Capital.
Alphalyse operates through Alphalyse A/S.
Yes. Alphalyse was acquired by Fidelio Capital in July 2025.

